Altimmune’s Promising GLP-1 Drug: Worth the Investment?by Mark Eisenberg 25.04.2024Altimmune's stock has seen a strong increase in value, surpassing Eli Lilly and Novo Nordisk. However, there are risks involved.
Is Snowflake Stock a Buy Now? Analysis of Growth Potentialby Mark Eisenberg 25.04.2024Snowflake stock traded at high multiples and although it may benefit from growth, the long-term outlook and management's actions raise ...
Is Berkshire Hathaway Stock Worth Investing In?by Mark Eisenberg 25.04.2024Find out if Berkshire Hathaway stock is a good buy by evaluating its book value. The Stock Advisor service has ...
TikTok Ban Bill Nearing Law: What’s Next?by Lilu Anderson 25.04.2024The bill to ban TikTok in the US is nearing passing into law. If it does, the consequences for the ...
Wall Street Bosses: Warning of Threats – Inflation, Recession, & Warby Terry Bingman 25.04.2024JPMorgan CEO Jamie Dimon, BlackRock's Larry Fink, and Blackstone's Steve Schwarzman express concerns about fear and uncertainty in markets. Dimon ...
Analyst Expects Cardano (ADA) Surge: MVRV Ratio Dropsby John Darbie 25.04.2024ADA, the native token of the Cardano network, has seen its MVRV Ratio dip below -22%, a level that previously ...
Netflix under fire for AI use in ‘What Jennifer Did’by John Darbie 25.04.2024Netflix's true crime documentary, What Jennifer Did, has raised eyebrows as it's revealed that the images used in the film ...
Is Now the Time to Buy Palantir Stock?by Mark Eisenberg 25.04.2024The recent surge in Palantir's stock price has investors wondering if they've missed out. However, despite the rise, the stock ...
Missed SoundHound AI? Buy Nvidia Insteadby Mark Eisenberg 25.04.2024Despite a pullback, SoundHound AI stock is trading at 22x sales, while Nvidia's growth has been stronger. SoundHound expects its ...
Ella Purnell Shines in Fallout Season 2 Approvalby Lilu Anderson 25.04.2024Ella Purnell shines as Lucy in Fallout series, delivering an engaging performance. The TV adaptation impresses, but beware of its ...